References
- Mahachai V, Walker K, Sevelius H, Thomason A BR. Antisecretory and serum gastric lowering effect of enprostil in patients with duodenal ulcer disease. Gastroenterology 1985; 89: 555–561
- McColI K EL, Buchanan N, Laferla G, Hearus J, Buchanan K, Crean G P. Effect of enprostil on gastric secretion and gastrin release in man. Gut 1986; 27: A607
- Navert H, Lamothe M, Level E, Tetreault L, Had-dad H. Evaluation of the gastrointestinal cyto-protective effects of enprostil following aspirin administration in man. Gastroenterology 1984; 86: 1194
- Cohen M M, McCready D R, Clark L, Sevelius H. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endo-scopic study. Gastroenterology 1985; 88: 382–386
- Bianchi Porro G, Parente F. Clinical safety of anti-ulcer prostaglandins: an overview. Prostaglandins and leuko-trienes in gastrointestinal diseases, W Domschke, H G Dammann. Springer Verlag, Berlin 1988; 204–209
- Navert H, Thomson A BR, Archambault A, et al. Treatment of gastric ulcer with enprostil. Am J Med 1986; 81(suppl 2A)75–79
- Bright-Asare P, Krejs G J, Santangelo W C, et al. Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analog. Am J Med 1986; 81(suppl 2A)64–68
- Bardhan K D, Lee F I, Bose K, et al. A comparison of enprostil and ranitidine in treatment of duodenal ulcer. J Clin Gastroenterol 1988; 10: 137–142
- Sanders K M. Role of prostaglandins in regulating gastric motility. Am J Physiol 1984; 247: G117–G126
- Tollström T, Hellström P M, Johansson C, Pernow B. Effects of prostaglandins E2 and F2α on motility of small intestine in man. DigDis Sci 1988; 33: 552–557
- Goa K L, Monk J P. Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 1987; 34: 539–559
- Jonderko K, Rudzki K, Skrzypek D. Background analysis and comparison of two solid food markers (DTPA and HSAM) in the measurement of human gastric emptying. Isotopenpraxis 1986; 22: 252–255
- Jonderko K. Comparative analysis of quantitative gastric emptying indices and power-exponential modelling of gastric emptying curves. Clin Phys Physiol Measure 1989; 10: 161–170
- Jonderko K, Kucio C, Skrzypek D. Slowed gastric evacuation accounts for the reduction of food intake by anorectic drugs. Eur J Clin Nutr 1988; 42: 627–631
- Moore J G, Alazraki N, Clay G D. Effect of synthetic prostaglandin E1 analog on gastric emptying of meals in man. Dig Dis Sci 1986; 31: 16–20
- Penston J G, Johnston D A, Wormsley K G. The effects of rioprostil on gastric emptying and intra-gastric acidity. Hepatogastroenterol 1986; 33: 120–122
- Ruwart M J, Rush B D. The effects of PGF2α, PGE2 and 16,16dimethyl-PGE2 on gastric emptying and small intestinal transit in rat. Prostaglandins 1984; 28: 915–928
- Dubois A, Gross H A, Richter J E, Ebert M H. Effect of bethanechol on gastric functions in primary anorexia nervosa. Dig Dis Sci 1981; 26: 598–600
- Fink S M, Lange R C, McCallum R W. Effect of metoclopramide on normal and delayed gastric emptying in gastroesophageal reflux patients. Dig Dis Sci 1983; 28: 1057–1061
- Horowitz M, Harding P E, Chatterton B E, Collins P J, Shearman D JC. Acute and chronic effects of domperidone on gastric emptying in diabetic auto-nomic neuropathy. Dig Dis Sci 1985; 30: 1–9
- Horowitz M, Maddox A, Harding P E, et al. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenter-ology 1987; 92: 1899–1907
- Minami H, McCallum R W. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 1984; 86: 1592–1610